INTELLIGENT DRUG DISCOVERY AND DEVELOPMENT 2003 (ID3860)

Venue: Wyndham Franklin Plaza Hotel

Location: Philadelphia, Pennsylvania, United States

Event Date/Time: May 28, 2003 End Date/Time: May 30, 2003
Registration Date: May 28, 2003
Early Registration Date: Mar 07, 2003
Abstract Submission Date: Apr 11, 2003
Paper Submission Date: Apr 11, 2003
Report as Spam

Description

Why You Should Attend:
• Focus on high-content screening and cellular assay development. Hear from Lilly, Aventis, Roche, and
Johnson & Johnson
• Hear success stories and compare strategies from Merck, Chiron, Amgen, and Millennium
• Learn how chemical genomics affects drug screening from Infinity and Kalypsys
• Spend a day learning about novel screening approaches, including cell-arrays, NMR screening, and
zebrafish assays
• Discover new detection technologies
Why You Should Attend:
• Learn how large pharma integrates cheminformatics in drug discovery
• Hear about novel chemometric approaches
• Get special topic coverage of literature data mining
• Hear success stories in library design and virtual screening from industry leaders
• Explore new technologies to provide more parallel optimization of leads
• Hear how big pharma has applied techniques to improve lead evalution
• See why some existing strategies for lead optimization fail
• View presentations from GlaxoSmithKline, Bristol-Myers Squibb, Amersham Biosciences, NCI-NIH, and
many others
• Differentiating inherent risks between novel targets
• Front-loading risk in discovery to reduce downstream attrition
• Creating R&D and marketing synergies to better manage risk
• Options to improve the profitability of your portfolio via strategic licensing

Venue

17th and Race Streets
Philadelphia
Pennsylvania
United States
MORE INFO ON THIS VENUE